Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP580641.RAJJxD2vueCVJc7E5FJisnr_rFe4vuXpoFvyb0KkINygc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP580641.RAJJxD2vueCVJc7E5FJisnr_rFe4vuXpoFvyb0KkINygc130_assertion type Assertion NP580641.RAJJxD2vueCVJc7E5FJisnr_rFe4vuXpoFvyb0KkINygc130_head.
- NP580641.RAJJxD2vueCVJc7E5FJisnr_rFe4vuXpoFvyb0KkINygc130_assertion description "[Immunohistochemical analysis detected robust and frequent expression of C35 protein, including 32% of grade 1 and 66% of grades 2 and 3 infiltrating ductal carcinomas of the breast (in contrast to 20% overexpressing HER-2/neu), 38% of infiltrating lobular carcinoma (typically HER-2/neu negative), as well as tumors arising in other tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580641.RAJJxD2vueCVJc7E5FJisnr_rFe4vuXpoFvyb0KkINygc130_provenance.
- NP580641.RAJJxD2vueCVJc7E5FJisnr_rFe4vuXpoFvyb0KkINygc130_assertion evidence source_evidence_literature NP580641.RAJJxD2vueCVJc7E5FJisnr_rFe4vuXpoFvyb0KkINygc130_provenance.
- NP580641.RAJJxD2vueCVJc7E5FJisnr_rFe4vuXpoFvyb0KkINygc130_assertion SIO_000772 17121940 NP580641.RAJJxD2vueCVJc7E5FJisnr_rFe4vuXpoFvyb0KkINygc130_provenance.
- NP580641.RAJJxD2vueCVJc7E5FJisnr_rFe4vuXpoFvyb0KkINygc130_assertion wasDerivedFrom befree-2016 NP580641.RAJJxD2vueCVJc7E5FJisnr_rFe4vuXpoFvyb0KkINygc130_provenance.
- NP580641.RAJJxD2vueCVJc7E5FJisnr_rFe4vuXpoFvyb0KkINygc130_assertion wasGeneratedBy ECO_0000203 NP580641.RAJJxD2vueCVJc7E5FJisnr_rFe4vuXpoFvyb0KkINygc130_provenance.